Pandion Therapeutics Inc 's ROA from the fourth quarter of 2020 to the fourth quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pandion Therapeutics Inc 's ROA in the fourth quarter of 2020?
Pandion Therapeutics Inc recorded a cumulative net loss of $-6 million during 12 months ending in the fourth quarter of 2020, resulting in a negative return on assets (ROA) of -4.12%.

However, within the Healthcare sector 277 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2020 from to 3326.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) II. Quarter	(Dec 31 2019) IV. Quarter
Y / Y Total Assets Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-6	-31	-26	-23	-22
Return On Assets (TTM)	-4.12 %	-31.75 %	-66.93 %	-213.05 %	-
PAND's Total Ranking	# 3326	#	#	#	#
Total Assets (TTM) in million	227	240	114	42	0
Seq. Total Assets Change	-5.44 %	111.83 %	168.53 %	-	-
Seq. Net Income Change	-	-	-	-	-

PAND's 5 Years Annual ROA >> Back to PAND Management Effectiveness >> Compare PAND ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 97
Sector	# 278
Overall	# 3234

Return On Assets Statistics
High	Average	Low
-4.26 %	-4.26 %	-4.26 %
(Dec 31 2020)

Financial Statements
Pandion Therapeutics Inc 's Assets	$ 227 million	PAND's Balance sheet
Pandion Therapeutics Inc 's Income	$ 20 million	Quarterly PAND's Income Statement
PAND's Income by Division		See PAND's Income by Division

Annual Return On Assets	(Dec 31 2020) FY 2020	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	227	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-38	0	0	0	0
Annual Return On Assets	-16.76 %	-	-	-	-

PAND's 5 Years Annual ROA >> Back to PAND Management Effectiveness >> Compare PAND ROA to its Competitors

More Return On Assets Ratios
PAND's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PAND's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PAND's Competitors
Subscribers only: Roa for Pandion Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for PAND's Customers

You may also want to know
PAND's Roi	PAND's Inventory Turnover Ratio	PAND's Growth Rates	PAND's Dividend Comparisons
	PAND's Profitability Ratios	PAND's Asset Turnover Ratio	PAND's Dividend Growth
PAND's Roe	PAND's Valuation Ratios	PAND's Financial Strength Ratios	PAND's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2020, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:10:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.